| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/09/2000 | US6060588 Bap-1 proteins |
| 05/09/2000 | US6060587 Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle |
| 05/09/2000 | US6060456 Chimeric oligonucleoside compounds |
| 05/09/2000 | US6060455 Cationic and polycationic amphiphiles, reactives containing the same and their use |
| 05/09/2000 | US6060450 Administering tau-interferon to treat multiple sclerosis, rheumatoid arthritis, diabetes, and lupus |
| 05/09/2000 | US6060317 Method of transducing mammalian cells, and products related thereto |
| 05/09/2000 | US6060316 Methods of targeting of viral entry |
| 05/09/2000 | US6060315 Method for facilitating the introduction of material into cells |
| 05/09/2000 | US6060310 Transcription factor decoy and tumor growth inhibitor |
| 05/09/2000 | US6060308 RNA respiratory syncytial virus vaccines |
| 05/09/2000 | US6060305 Non-toxic, non-toxigenic, non-pathogenic Fusarium expression system |
| 05/09/2000 | US6060303 Use in screening assays and as pharmaceuticals. |
| 05/09/2000 | US6060302 Human phospholipase C-α and DNA sequence encoding the same |
| 05/09/2000 | US6060301 Vector containing MTS1E1β gene |
| 05/09/2000 | US6060300 Thrombin muteins as antidotes for thrombin inhibitors |
| 05/09/2000 | US6060299 Enzyme exhibiting mannase activity, cleaning compositions, and methods of use |
| 05/09/2000 | US6060297 Rho protein |
| 05/09/2000 | US6060296 Protein kinases |
| 05/09/2000 | US6060295 Nucleic acids and expression systems encoding tyrosylprotein sulfo transferases |
| 05/09/2000 | US6060294 Alanyl tRNA synthetase from Staphylococcus aureus |
| 05/09/2000 | US6060290 Esterase and methods for the production of optically active chroman compounds |
| 05/09/2000 | US6060288 Simple, fast, reliable detection of target nucleic acid by using two or more complementary oligonucleotides immobilized onto optical fiber, contacting end of fiber with test sample, amplifying target sequence, detecting optical signal produced |
| 05/09/2000 | US6060285 Process for the production of hetero-bispecific antibodies |
| 05/09/2000 | US6060284 Polynucleotide coding for antigenic polypeptides of specific amino acid sequences; for diagnosis and therapy of immune and autoimmune disorders; polymerase chain reaction primers; hybridization probes |
| 05/09/2000 | US6060283 Nucleotide and amino acid sequences; to treat and/or prevent malignant tumors, viral diseases, bacterial infections and immune diseases without serious side effects; viricides; bactericides; antitumor agents |
| 05/09/2000 | US6060282 Streptococcus pneumoniae gene sequence Dpj |
| 05/09/2000 | US6060281 Parasitic helminth PLA2 proteins and nucleic acid molecules |
| 05/09/2000 | US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins |
| 05/09/2000 | US6060278 Expressing recombinant human troponin c and t and a modified recombinant troponin i, then complexing by mixing in neutral ph, aqueous medium in presence of alkaline salt(s); for controls/calibrators in diagnosis of myocardial infarction |
| 05/09/2000 | US6060276 Nucleotide sequences for proteins involved in signal transduction; for assays to detect/measure ligands; diagnosis and therapy of endocrine disorders; gene therapy; antisense agents; transgenic animals |
| 05/09/2000 | US6060275 Sprouty protein and coding sequence |
| 05/09/2000 | US6060274 Extracellular expression of cellulose binding domains (CBD) using Bacillus |
| 05/09/2000 | US6060273 Multicistronic expression units and their use |
| 05/09/2000 | US6060272 Human G-protein coupled receptors |
| 05/09/2000 | US6060271 CDNA fragments corresponding to voltage gated sodium channel genes expressed in peripheral nerve |
| 05/09/2000 | US6060270 Central lumen bordered by polarized epithelium and produced by culturing in all-trans retinoic acid, transforming growth factor-beta-1 and either epidermal growth factor or transforming growth factor-alpha; for kidney disorders |
| 05/09/2000 | US6060264 Multiple drug resistance gene atrc of Aspergillus nidulans |
| 05/09/2000 | US6060263 Mammalian lysophosphatidic acid acyltransferase |
| 05/09/2000 | US6060259 Having molecular weight in presence of sodium dodecyl sulfate of between 44.5 and 47.5 kilodaltons; for detecting or monitoring the development of tuberculosis in man or cattle |
| 05/09/2000 | US6060257 Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
| 05/09/2000 | US6060252 Amplification and detection of shigella spp. and enteroinvasive strains of Escherichia coli |
| 05/09/2000 | US6060250 Human transferases |
| 05/09/2000 | US6060249 Method of selection for genes encoding secreted and transmembrane proteins |
| 05/09/2000 | US6060247 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
| 05/09/2000 | US6060246 Rapid pairing reagent is a solid substrate with a capture component, effective to rapidly and non-selectively bind polynucleotides, and a target-specific probe |
| 05/09/2000 | US6060244 Genes and genetic elements associated with sensitivity to chemotherapeutic drugs |
| 05/09/2000 | US6060241 Compositions and methods relating to drug discovery and detection and treatment of gastrointestinal diseases |
| 05/09/2000 | US6060239 Cellubrevin homologs |
| 05/09/2000 | US6060238 Method and composition for regulating apoptosis |
| 05/09/2000 | US6060236 Immunoassay diagnosis in animals or humans by contacting serum sample with virus encoded proteins, and determining the presence of antibody-antigen complexes as indication of infection |
| 05/09/2000 | US6060234 Novel erythromycin derivatives in which methyl groups on the macrolactone ring have been substituted with hydrogen, ethyl, and/or hydroxy groups |
| 05/09/2000 | US6060065 Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission |
| 05/09/2000 | US6060064 Chimeric virus-like particle antigen presentation and delivery system |
| 05/09/2000 | US6060059 Haemophilus adhesion proteins |
| 05/09/2000 | US6060057 Cloning and sequencing of allergens of Dermatophagoides (house dust mite) |
| 05/09/2000 | US6060055 Inducing immunological response in a mammal which comprises delivering a nucleic acid vector to direct expression of div1b polypeptide for expressing said div1b polypeptide in vivo |
| 05/09/2000 | US6060054 Product for T lymphocyte immunosuppression |
| 05/09/2000 | US6060052 Expanding primitive stem cells for restoration of hematopoietic capabilities and for providing modified human stem cells for gene therapy applications; transplantation of human hematopoietic stem cells |
| 05/09/2000 | US6060047 Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production |
| 05/09/2000 | US6060037 Conjugated compounds which comprise an st receptor binding moiety and a radiostable active moiety |
| 05/09/2000 | CA2100586C Htlv-i and htlv-ii peptide antigens and methods |
| 05/09/2000 | CA2057860C Immunoactive peptides and antibodies and their use in anti-allergy treatment |
| 05/06/2000 | CA2286850A1 Method for producing double-stranded dna whose terminal homopolymer part is eliminated and method for determining nucleotide sequence |
| 05/04/2000 | WO2000025138A2 Methods of diagnosing or prognosing alzheimer's disease |
| 05/04/2000 | WO2000025136A1 Method for gold deposition |
| 05/04/2000 | WO2000024940A1 Cellular arrays and methods of detecting and using genetic disorder markers |
| 05/04/2000 | WO2000024939A1 Complexity management and analysis of genomic dna |
| 05/04/2000 | WO2000024937A2 Parallel methods for genomic analysis |
| 05/04/2000 | WO2000024934A1 Phytomics: a genomic-based approach to herbal compositions |
| 05/04/2000 | WO2000024932A1 Methods of identifying and characterizing mutations within bacterial dna gyrase and fabi |
| 05/04/2000 | WO2000024927A1 Methods and means for isolating and purifying nucleic acids on surfaces |
| 05/04/2000 | WO2000024924A2 Methods for screening protease variants for use in detergent compositions |
| 05/04/2000 | WO2000024922A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 05/04/2000 | WO2000024917A1 Targeted gene modification by parvoviral vectors |
| 05/04/2000 | WO2000024916A1 Improved aav vector production |
| 05/04/2000 | WO2000024915A2 Plant raffinose synthase homologs |
| 05/04/2000 | WO2000024914A2 Apomixis conferred by expression of serk interacting proteins |
| 05/04/2000 | WO2000024913A2 Mn gene and protein |
| 05/04/2000 | WO2000024912A1 Use of a self-cleaving rna motif to modulate gene expression |
| 05/04/2000 | WO2000024911A2 Human phospholipases |
| 05/04/2000 | WO2000024910A1 Process of purification of low density lipoprotein associated phospholipase a2 using immobilized metal affinity chromatography |
| 05/04/2000 | WO2000024909A1 C.fimi glycosyl hydrolase containing a mannan binding domain |
| 05/04/2000 | WO2000024908A1 IDENTIFICATION OF NOVEL SUBSTRATE I-TRAF OF IKK-i KINASE |
| 05/04/2000 | WO2000024907A2 Library of novel "unnatural" natural products |
| 05/04/2000 | WO2000024906A1 Sequence encoding cysdv coat protein |
| 05/04/2000 | WO2000024905A1 Plant-optimized genes encoding pesticidal cytc-type toxins |
| 05/04/2000 | WO2000024904A1 PLANT-OPTIMIZED POLYNUCLEOTIDES ENCODING APPROXIMATELY 15 kDa AND APPROXIMATELY 45 kDa PESTICIDAL PROTEINS |
| 05/04/2000 | WO2000024903A2 Plant-optimized polynucleotides encoding pesticidal 43f- and 80jj1/130-type proteins |
| 05/04/2000 | WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000024901A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000024900A1 Maize kin17 orthologues and uses thereof |
| 05/04/2000 | WO2000024899A2 Interleukin-1 homolog zil1a4 |
| 05/04/2000 | WO2000024898A1 Gene for a thrombin inhibitor from the triatoma genus and protein with a thrombin-inhibiting effect |
| 05/04/2000 | WO2000024897A1 Cell surface molecule-induced macrophage activation |
| 05/04/2000 | WO2000024896A2 Biological material for preparing pharmaceutical compositions for treating mammals |
| 05/04/2000 | WO2000024895A2 Method and model for hair pigmentation |
| 05/04/2000 | WO2000024894A1 Plant-optimized marker genes |
| 05/04/2000 | WO2000024893A2 Methods and compositions for the prevention and treatment of anemia |
| 05/04/2000 | WO2000024892A1 Genes expressed in human monocytes and human macrophages |
| 05/04/2000 | WO2000024891A1 Novel g protein-coupled receptor proteins and dnas thereof |